Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057746 · ClinicalTrials.gov registry record · Phase 2
Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
- 265
- Enrollment target
NCT00057746 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 265 participants.
The verdict
NCT00057746, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 265 participants
- Enrollment target
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective in preventing brain metastases in patients with limited-stage small cell lung cancer while taking into account chronic neurotoxicity from radiation therapy. PURPOSE: This randomized phase II trial compares the incidence of chronic neurotoxicity between three different brain irradiation regimens. The corresponding phase III component addressing the prevention of brain metastases was run by EORTC and reported separately (NCT00005062).
Interventions
- RADIATION Prophylactic cranial irradiation, 2.5 Gy fx
- RADIATION Prophylactic cranial irradiation, 2.0 Gy fx
- RADIATION Prophylactic cranial irradiation, 1.5 Gy fx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2003-02 |
| Est. Completion | 2013-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00057746
The ClinicalTrials.gov registry entry for NCT00057746 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Prophylactic cranial irradiation, 2.5 Gy fx is the first listed.
NCT00057746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00057746 about?
NCT00057746 is a clinical study titled "Brain Irradiation in Treating Patients With Limited-Stage Small Cell Lung Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which radiation therapy regimen is more effective in preventing brain metastases in patients with limited-stage small cell lung cancer while taking into account chronic neurotoxicity from radiation therap...
What is the current status of trial NCT00057746?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 265 participants. The study started on 2003-02. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00057746?
The interventions under investigation include: Prophylactic cranial irradiation, 2.5 Gy fx (RADIATION), Prophylactic cranial irradiation, 2.0 Gy fx (RADIATION), Prophylactic cranial irradiation, 1.5 Gy fx (RADIATION).
Who is sponsoring clinical trial NCT00057746?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.